Stephen J. Dipalma - Net Worth and Insider Trading

Over the past 18 months, Stephen J. Dipalma made no insider transaction in Generation Bio Co (GBIO). Other recent insider transactions involving Generation Bio Co (GBIO) include a net sale of 10,590 shares made by Antoinette Paone , a net purchase of 20,000 shares made by Dannielle Appelhans , and a net purchase of 342,960 shares made by Rowland Charles A Jr .

In summary, during the past 3 months, insiders sold 0 shares of Generation Bio Co (GBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 12,455 shares of Generation Bio Co (GBIO) were sold and 551,455 shares were bought by its insiders, resulting in a net purchase of 539,000 shares.

Generation Bio Co (GBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Anchiano Therapeutics Ltd (CMMB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anchiano Therapeutics Ltd (CMMB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anchiano Therapeutics Ltd (CMMB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Stephen J. Dipalma made no insider transaction in Spero Therapeutics Inc (SPRO). Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 91,515 shares made by Sath Shukla , a net sale of 85,121 shares made by Ankit Mahadevia , and a net sale of 36,219 shares made by Timothy Keutzer .

In summary, during the past 3 months, insiders sold 0 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 316,580 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 316,580 shares.

Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Interleukin Genetics Inc (ILIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Interleukin Genetics Inc (ILIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Interleukin Genetics Inc (ILIU)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Scorpius Holdings Inc (SCPX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Scorpius Holdings Inc (SCPX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Scorpius Holdings Inc (SCPX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of SELLAS Life Sciences Group Inc (SLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of SELLAS Life Sciences Group Inc (SLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

SELLAS Life Sciences Group Inc (SLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Stephen J. Dipalma made no insider transaction in Chemomab Therapeutics Ltd (CMMB). Other recent insider transactions involving Chemomab Therapeutics Ltd (CMMB) include a net sale of 336,900 shares made by Orbimed Israel Biofund Gp Limited Partnership ,

In summary, during the past 3 months, insiders sold 0 shares of Chemomab Therapeutics Ltd (CMMB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 336,900 shares of Chemomab Therapeutics Ltd (CMMB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 336,900 shares.

Chemomab Therapeutics Ltd (CMMB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Stephen J. Dipalma made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,833,697 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .

In summary, during the past 3 months, insiders sold 7,523 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 7,523 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,667,030 shares were bought by its insiders, resulting in a net purchase of 2,659,507 shares.

Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Stephen J. Dipalma made no insider transaction in Solid Biosciences Inc (SLDB). Other recent insider transactions involving Solid Biosciences Inc (SLDB) include a net sale of 3,753 shares made by Ilan Ganot , a net purchase of 3,410,713 shares made by Perceptive Life Sciences Master Fund Ltd , and a net purchase of 904,160 shares made by Ra Capital Healthcare Fund Lp .

In summary, during the past 3 months, insiders sold 462 shares of Solid Biosciences Inc (SLDB) in total and bought 0 shares, with a net sale of 462 shares. During the past 18 months, 26,233 shares of Solid Biosciences Inc (SLDB) were sold and 4,314,873 shares were bought by its insiders, resulting in a net purchase of 4,288,640 shares.

Solid Biosciences Inc (SLDB)'s detailed insider trading history can be found in Insider Trading Tracker table.